Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities)
Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities)
Commack, New York, United States21 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 2 | 2026-10-05 | NCT07335796 | |
| Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 3 | 2026-09-18 | NCT07548164 | |
| HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-08-20 | NCT07459673 | |
| A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast adenocarcinoma, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 2 | 2026-08-17 | NCT07768436 | |
| Radiation Therapy Approaches for People With Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 2 | 2026-08-12 | NCT07751159 | |
| A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer | DNA Virus Infections, Head and Neck Neoplasms, Herpesviridae infectious disease, Infections, Kaposi's sarcoma, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Adnexal and Skin Appendage, Neoplasms, Connective and Soft Tissue, Neoplasms, Ductal, Lobular, and Medullary, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Tumor Virus Infections, adenocarcinoma, angiosarcoma, basal cell carcinoma, basal cell neoplasm, carcinoma, cutaneous neuroendocrine carcinoma, epithelial neoplasm, extramammary Paget disease, head and neck squamous cell carcinoma, melanocytic neoplasm, melanoma, metastatic malignant neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, polyomavirus infectious disease, primitive neuroectodermal tumor, refractory malignant neoplasm, sarcoma, sebaceous adenocarcinoma, skin appendage carcinoma, skin disorder, skin neoplasm, skin squamous cell carcinoma, squamous cell carcinoma, squamous cell neoplasm, vascular cancer, viral infectious disease | Recruiting | Phase 1 | 2026-08-12 | NCT05859074 | |
| A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, non-Hodgkin lymphoma, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Not stated | 2026-08-06 | NCT07249528 | |
| A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 4 | 2026-07-10 | NCT07220967 | |
| A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant | Hemic and Lymphatic Diseases, Neoplasms by Site, graft versus host disease, hematologic disorder, hematopoietic and lymphoid system neoplasm, immune system disorder, neoplasm | Recruiting | Phase 2 | 2026-07-07 | NCT07359859 | |
| A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Phase 1 | 2026-06-26 | NCT07671339 | |
| A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma | Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, peripheral neuropathy, transitional cell carcinoma, urothelial carcinoma | Recruiting | Not stated | 2026-05-29 | NCT07390617 | |
| A Study of Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-05-29 | NCT05203445 | |
| A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, esophageal adenocarcinoma, esophageal disorder, gastric neoplasm, neoplasm, stomach disorder | Active, not recruiting | Phase 2 | 2026-05-15 | NCT06251973 | |
| Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism | Deep Vein Thrombosis, Embolism and Thrombosis, Thromboembolism, Venous Thrombosis, cardiovascular disorder, thrombotic disease, vascular disorder, venous thromboembolism | Recruiting | Not applicable | 2026-05-05 | NCT07399977 | |
| Factors Associated With Breast Cancer Risks and Outcomes | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not stated | 2026-04-17 | NCT07294703 | |
| A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC) | Head and Neck Neoplasms, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, neoplasm, otorhinolaryngologic disease | Recruiting | Phase 2 | 2026-04-13 | NCT05307939 | |
| A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm | Active, not recruiting | Phase 1 | 2026-03-27 | NCT06192888 | |
| A Study of Pasireotide in People With Prolactinoma | Prolactin-Producing Pituitary Tumor | Recruiting | Phase 2 | 2026-03-04 | NCT06295952 | |
| A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-02-23 | NCT07428044 | |
| Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, clear cell renal carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorder | Active, not recruiting | Phase 2 | 2026-01-14 | NCT05239533 | |
| Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type | Pathologic Processes, Pathological Conditions, Signs and Symptoms, disease | Active, not recruiting | Phase 2 | 2025-10-23 | NCT03728972 |